SCHEMBL2585792

SCHEMBL2585792

Nc1[c]ccc(-c2cccc(N)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.56
MAP4K4 O95819 6/20 0.47
MEN1 O00255 2/20 0.46
PSIP1 O75475 1/20 0.46
AXL P30530 1/20 0.46
MKNK1 Q9BUB5 1/20 0.46
MKNK2 Q9HBH9 1/20 0.46
CYP3A4 P08684 2/20 0.44
CASP1 P29466 1/20 0.44
RECQL P46063 1/20 0.44
MCL1 Q07820 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
PDPK1 O15530 1/20 0.40
CYP17A1 P05093 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3296186 0.83 MAOA (0.48) MAOAMAP4K4MEN1CYP3A4MCL1
SCHEMBL27588583 0.80 HSD17B1 (0.54) MAP4K4CYP3A4CA12CA1CA2
SCHEMBL21224463 0.80 TAAR1 (0.47) MAP4K4ALDH1A1
SCHEMBL251095 0.79 MAOA (0.83) MAOAMAP4K4MEN1PSIP1AXL
SCHEMBL30500254 0.79 MAOA (0.83) MAOAMAP4K4MEN1PSIP1AXL
SCHEMBL29403794 0.79 MAOA (0.83) MAOAMAP4K4MEN1PSIP1AXL
SCHEMBL27588635 0.78 TDP1 (0.50) MAOAMEN1CYP3A4CA12CA1
SCHEMBL695090 0.78 MAOA (0.67) MAOAMAP4K4MEN1PSIP1AXL
SCHEMBL27606344 0.77 NOS3 (0.41)
Water SCHEMBL3862803 0.77 MAOA (0.79) MAOAMAP4K4MEN1PSIP1AXL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114761000-A Substituted 1, 6-naphthyridine inhibitors of CDK5 金翅雀生物公司 2022-07-15 CN claimed
EP-2066647-B1 BENZOXAZOLES AND OXAZOLOPYRIDINES BEING USEFUL AS JANUS KINASES INHIBITORS NOVARTIS AG (CH) 2011-11-09 EP claimed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed